Page 2 - Timothyp Walbert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

Tcwp LLC purchased a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 390 shares of the biopharmaceutical company’s stock, valued at approximately $41,000. Several other hedge funds have also recently added to or reduced their stakes in HZNP. Nuveen Asset […]

Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. The firm currently has a $100.00 price target on the biopharmaceutical company’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 5.44% […]

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) – Equities research analysts at SVB Leerink issued their Q2 2022 earnings per share (EPS) estimates for Horizon Therapeutics Public in a note issued to investors on Sunday, May 22nd. SVB Leerink analyst D. Risinger forecasts that the biopharmaceutical company will post earnings per share of $1.33 […]

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) CEO Timothy P. Walbert sold 25,000 shares of the stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $90.00, for a total value of $2,250,000.00. Following the transaction, the chief executive officer now directly owns 460,549 shares […]